Background
Methods
Methods-general
Setting and model
Targeted population
Comparators
Time horizon
Discount rate
Outcome
Choice of outcomes
Measurement of effectiveness
Modeled parameters
State | Annual failure rate (%) | Allocation | Data source | |
---|---|---|---|---|
Allocated to | Prob. | |||
Implant | 0.52 | second Implant | 1 | Jung et al. (2012) [11] (systematic review) |
second Implant | 2 | IFDP | 1 | Mardinger et al. (2012) [14] (retrospective) |
IFDP | 11 | second IFDP | 0.998 | Aoyama et al. (2008) [15] (retrospective) |
RPD | 0.002 | Pjetursson et al. (2007) [12] (systermatic review) | ||
second IFDP | 15 | RPD | 1 | assumption |
PFDP | 4.4 | second PFDP | 0.998 | Torabinehad et al. (2007) [13] (systematic review) |
RPD | 0.002 | Pjetursson et al. (2007) [12] (systermatic review) | ||
second PFDP | 8.4 | RPD | 1 | assumption |
RPD | 16.8 | MT | 1 | Jepson et al. (1995) [16] (retrospective) |
all state | 50 years: 0.0016 | dead | 1 | |
51 years: 0.0017 | ||||
: | ||||
80 years: 0.0252 |
Costs
Results
Study parameters
State | Kennedy Classification | Eichner Classification | Distribution | No. of patients | Age Mean ± 1SD | Distribution parameters Mean ± 1SD |
---|---|---|---|---|---|---|
Implant | Beta | 168 | 61.7 ± 9.8 | 0.88 ± 0.14 | ||
II | B1-B2 | |||||
lost Implant | Beta | 32 | 61.1 ± 9.4 | 0.71 ± 0.23 | ||
FDP | Beta | 65 | 59.0 ± 11.4 | 0.83 ± 0.13 | ||
III | A2-A3-B1-B2 | |||||
lost FDP | Beta | 66 | 54.8 ± 11.5 | 0.68 ± 0.17 | ||
RPD | II-III | B1-B2 | Beta | 45 | 63.8 ± 10.3 | 0.71 ± 0.23 |
MT | II | B1-B2 | Beta | 184 | 59.1 ± 11.0 | 0.70 ± 0.18 |
State | Distribution | Distibution Mean ± 1SD (€) | Data source |
---|---|---|---|
Implant | Gamma | 2744 ± 274.4 | Interpolated fromhealth insurance treatment costsof Japan |
IFDP | Gamma | 420 ± 42.0 | Health insurance treatment costsof Japan |
PFDP | Gamma | 2618 ± 261.8 | Private practice |
Implant•FDP•MT maintenance | Gamma | 261.8 ± 26.2 | Interpolated from health insurance treatment costs of Japan |
RPD | Gamma | 368 ± 36.8 | Health insurance treatement costs of Japan |
RPD maintenance | Gamma | 305 ± 43.6 | Health insurance treatment costs of Japan |
Incremental costs and effectiveness
Category | Strategy | Cost | Incr cost | Eff | Incr eff | Incr C/E (ICER) |
---|---|---|---|---|---|---|
Excluding dominated | ||||||
Undominated | IFDP | 6611.2 | 17.8 | |||
Undominated | Implant | 8461.1 | 1849.9 | 19.1 | 1.3 | 1423 |